Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II exploratory efficacy study of artemisinin-derived ethylether amine maleate tablets in systemic lupus erythematosus
CTR20190588Phase 2Completed
- Sponsor
- Shanghai Institute of Materia Medica
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of artemisinin ethyl ether amine maleate in systemic lupus erythematosus (SLE), sponsored by Shanghai Institute of Materia Medica. Started Apr 2019; status: completed.
02
Drugs
artemisinin ethyl ether amine maleate
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on CTR20190588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190588.